Abstract
Purpose
To present the data on primary hyperparathyroidism (PHPT) in pregnancy from India obtained from a large database maintained over 15 years.
Methods
We retrieved data of all women with gestational PHPT from the Indian PHPT registry between July 2005 and January 2020, and compared their clinical, biochemical, and other characteristics with age-matched non-pregnant women with PHPT.
Results
Out of 386 women, eight had gestational PHPT (2.1%). The common presenting manifestations were acute pancreatitis (50%) and renal stone disease (50%); two were asymptomatic. Five women (62.5%) had a history of prior miscarriages. Seven patients (88%) had preeclampsia during the present gestation. Serum calcium and intact parathyroid hormone (iPTH) were not statistically different from the age-matched non-pregnant PHPT group. Six patients with mild-to-moderate hypercalcemia were medically managed with hydration with/without cinacalcet while one patient underwent percutaneous ethanol ablation of the parathyroid adenoma; none underwent surgery during pregnancy. Mean serum calcium maintained from treatment initiation till delivery was 10.5 ± 0.4 mg/dl. One patient had spontaneous preterm delivery at 36 weeks; the remaining patients had normal vaginal delivery at term. None had severe preeclampsia/eclampsia. Fetal outcomes included low birth weight in three newborns (37.5%); two of them had hypocalcemic seizures.
Conclusion
The prevalence of gestational PHPT was 2.1% in this largest Indian PHPT cohort, which is higher than that reported from the West (< 1%). Gestational PHPT can lead to preeclampsia and miscarriage. Pregnant PHPT patients with mild-to-moderate hypercalcemia can be managed with hydration/cinacalcet; however, long-term safety data and large-scale randomized controlled trials are required.
Similar content being viewed by others
Data availability
Anonymous data sheets will be made available on reasonable request to the corresponding author.
References
Bilezikian JP (2018) Primary hyperparathyroidism. J Clin Endocrinol Metab 103:3993–4004. https://doi.org/10.1210/jc.2018-01225
DiMarco AN, Meeran K, Christakis I et al (2019) Seventeen cases of primary hyperparathyroidism in pregnancy: a call for management guidelines. J Endocr Soc 3:1009–1021. https://doi.org/10.1210/js.2018-00340
Gokkaya N, Gungor A, Bilen A et al (2016) Primary hyperparathyroidism in pregnancy: a case series and literature review. Gynecol Endocrinol 32:783–786. https://doi.org/10.1080/09513590.2016.1188916
Norman J, Politz D, Politz L (2009) Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention. Clin Endocrinol 71:104–109. https://doi.org/10.1111/j.1365-2265.2008.03495.x
McMullen TPW, Learoyd DL, Williams DC et al (2010) Hyperparathyroidism in pregnancy: options for localization and surgical therapy. World J Surg 34:1811–1816. https://doi.org/10.1007/s00268-010-0569-2
Som M, Stroup JS (2011) Primary hyperparathyroidism and pregnancy. Bayl Univ Med Cent Proc 24:220–223. https://doi.org/10.1080/08998280.2011.11928719
Schnatz PF, Curry SL (2002) Primary hyperparathyroidism in pregnancy:evidence-based management. Obstet Gynecol Surv 57:365–376. https://doi.org/10.1097/00006254-200206000-00022
Hirsch D, Kopel V, Nadler V et al (2015) Pregnancy outcomes in women with primary hyperparathyroidism. J Clin Endocrinol Metab 100:2115–2122. https://doi.org/10.1210/jc.2015-1110
Abood A, Vestergaard P (2014) Pregnancy outcomes in women with primary hyperparathyroidism. Eur J Endocrinol 171:69–76. https://doi.org/10.1530/EJE-13-0966
Bhadada SK, Arya AK, Mukhopadhyay S et al (2018) Primary hyperparathyroidism: insights from the Indian PHPT registry. J Bone Miner Metab 36:238–245. https://doi.org/10.1007/s00774-017-0833-8
Sharma R (2017) Hyperparathyroidism during pregnancy- a diagnostic and therapeutic challenge. J Clin Diagn Res. https://doi.org/10.7860/JCDR/2017/25948.10688
Panchani R, Varma T, Goyal A, Tripathi S (2013) Parathyroid carcinoma masquerading as morning sickness in pregnancy. Indian J Endocrinol Metab 17:198. https://doi.org/10.4103/2230-8210.119570
Jibhkate S, Valand A, Ansari S, Bharambe B (2014) Hyperparathyroidism complicating pregnancy: a diagnostic challenge? J Postgrad Med 60:329. https://doi.org/10.4103/0022-3859.138825
Bhansali A, Jaini V, Prasadi GRV et al (1999) Bad obstetric history: an unusual presenting manifestation of primary hyperparathyroidism. Aust N Z J Obstet Gynaecol 39:376–377. https://doi.org/10.1111/j.1479-828X.1999.tb03423.x
Bansal S, Kaushik RM, Kaushik R et al (2020) Primary hyperparathyroidism presenting as severe hypercalcemia with acute pancreatitis in pregnancy. Gynecol Endocrinol 36:469–472. https://doi.org/10.1080/09513590.2019.1698028
Aggarwal A, Wadhwa R, Aggarwal V et al (2019) Primary hyperparathyroidism in pregnancy: a multicenter case series of 4 patients from Northern India. J Obstet Gynecol India 69:31–35. https://doi.org/10.1007/s13224-018-1148-y
Kokrdova Z (2010) Pregnancy and primary hyperparathyroidism. J Obstet Gynaecol 30:57–59. https://doi.org/10.3109/01443610903315611
Kort KC, Schiller HJ, Numann PJ (1999) Hyperparathyroidism and pregnancy. Am J Surg 177:66–68. https://doi.org/10.1016/S0002-9610(98)00302-X
García MA, Feria MA, Moreno AS et al (2004) Primary hyperparathyroidism in pregnancy. Gynecol Endocrinol 19:111–114. https://doi.org/10.1080/09513590400002334
Song A, Wang W, Chen S et al (2019) Primary hyperparathyroidism during pregnancy: a case series of 8 patients. Endocr Pract 25:1127–1136. https://doi.org/10.4158/EP-2019-0035
Varshney S, Bhadada SK, Saikia UN et al (2013) Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians. Eur J Endocrinol 169:109–116. https://doi.org/10.1530/EJE-13-0085
Tachamo N, Timilsina B, Dhital R et al (2018) Primary hyperparathyroidism in pregnancy: successful parathyroidectomy during first trimester. Case Rep Endocrinol 2018:5493917. https://doi.org/10.1155/2018/5493917
Malekar-Raikar S, Sinnott BP (2011) Primary hyperparathyroidism in pregnancy—a rare cause of life-threatening hypercalcemia: case report and literature review. Case Rep Endocrinol 2011:1–6. https://doi.org/10.1155/2011/520516
Gehlert J, Morton A (2019) Hypercalcaemia during pregnancy: review of maternal and fetal complications, investigations, and management. Obstet Med 12:175–179. https://doi.org/10.1177/1753495X18799569
Iqbal A, Prince LR, Novodvorsky P et al (2019) Effect of hypoglycemia on inflammatory responses and the response to low-dose endotoxemia in humans. J Clin Endocrinol Metab 104:1187–1199. https://doi.org/10.1210/jc.2018-01168
Cherry TAD, Kauffman RP, Myles TD (2002) Primary hyperparathyroidism, hypercalcemic crisis and subsequent seizures occurring during pregnancy: a case report. J Matern Fetal Neonatal Med 12:349–352. https://doi.org/10.1080/jmf.12.5.349.352
Hu Y, Cui M, Sun Z et al (2017) Clinical presentation, management, and outcomes of primary hyperparathyroidism during pregnancy. Int J Endocrinol 2017:1–7. https://doi.org/10.1155/2017/3947423
Roizen J, Levine MA (2014) A meta-analysis comparing the biochemistry of primary hyperparathyroidism in youths to the biochemistry of primary hyperparathyroidism in adults. J Clin Endocrinol Metab 99:4555–4564. https://doi.org/10.1210/jc.2014-2268
Jovanovic M, Paunovic I, Zdravkovic V et al (2020) Case-control study of primary hyperparathyroidism in juvenile vs. adult patients. Int J Pediatr Otorhinolaryngol 131:109895. https://doi.org/10.1016/j.ijporl.2020.109895
Kamenický P, Lecoq A-L, Chanson P (2016) Primary hyperparathyroidism in pregnancy. Ann Endocrinol 77:169–171. https://doi.org/10.1016/j.ando.2016.04.010
Pallikadavath S, Stones RW (2005) Miscarriage in India: a population-based study. Fertil Steril 84:516–518. https://doi.org/10.1016/j.fertnstert.2005.02.023
Patki A, Chauhan N (2016) An epidemiology study to determine the prevalence and risk factors associated with recurrent spontaneous miscarriage in India. J Obstet Gynecol India 66:310–315. https://doi.org/10.1007/s13224-015-0682-0
Malik A, Jee B, Gupta SK (2019) Preeclampsia: disease biology and burden, its management strategies with reference to India. Pregnancy Hypertens 15:23–31. https://doi.org/10.1016/j.preghy.2018.10.011
Hultin H, Hellman P, Lundgren E et al (2009) Association of parathyroid adenoma and pregnancy with preeclampsia. J Clin Endocrinol Metab 94:3394–3399. https://doi.org/10.1210/jc.2009-0012
Schnatz PF, Thaxton S (2005) Parathyroidectomy in the third trimester of pregnancy. Obstet Gynecol Surv 60:672–682. https://doi.org/10.1097/01.ogx.0000180889.23678.fb
Hogg P, Thompson M, Burgess J (2020) The clinical expression and impact of multiple endocrine neoplasia 1 during pregnancy. Clin Endocrinol. https://doi.org/10.1111/cen.14252
Bodnar LM, Catov JM, Simhan HN et al (2007) Maternal vitamin d deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 92:3517–3522. https://doi.org/10.1210/jc.2007-0718
Lopez JM, Fardella CB (1989) Primary hyperparathyroidism: changes on biochemical and hormonal profile related to pregnancy. J Endocrinol Investig 12:127–129. https://doi.org/10.1007/BF03349939
Vera L, Oddo S, Di Iorgi N et al (2016) Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report and review of the literature. J Med Case Rep. https://doi.org/10.1186/s13256-016-1093-2
Edling K, Korenman S, Janzen C et al (2014) A pregnant dilemma: primary hyperparathyroidism due to parathyromatosis in pregnancy. Endocr Pract 20:e14–e17. https://doi.org/10.4158/EP13105.CR
Nadarasa K, Bailey M, Chahal H et al (2014) The use of cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma. Endocrinol Diabetes Metab Case Rep 2014:140056. https://doi.org/10.1530/EDM-14-0056
Bashir M, Mokhtar M, Baagar K et al (2019) A case of hyperparathyroidism treated with cinacalcet during pregnancy. AACE Clin Case Rep 5:e40–e43. https://doi.org/10.4158/ACCR-2018-0230
Horjus C, Groot I, Telting D et al (2009) Cinacalcet for hyperparathyroidism in pregnancy and puerperium. J Pediatr Endocrinol Metab 22:741–749. https://doi.org/10.1515/JPEM.2009.22.8.741
Rey E, Jacob C-E, Koolian M, Morin F (2016) Hypercalcemia in pregnancy - a multifaceted challenge: case reports and literature review. Clin Case Rep 4:1001–1008. https://doi.org/10.1002/ccr3.646
Rubin MR, Silverberg SJ (2017) Use of cinacalcet and 99mTc-sestamibi imaging during pregnancy. J Endocr Soc 1:1156–1159. https://doi.org/10.1210/js.2017-00308
Perin E, Cacciaguerra G, Lapenna R et al (2008) Primary hyperparathyroidism in pregnancy. Fertil Steril 90:2014.e13–2014.e15. https://doi.org/10.1016/j.fertnstert.2008.07.1731
Harman CR, Grant CS, Hay ID et al (1998) Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery 124:1011–1020. https://doi.org/10.1067/msy.1998.91826
Singh Ospina N, Thompson GB, Lee RA et al (2015) Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 100:E87–E90. https://doi.org/10.1210/jc.2014-3255
Rigg J, Gilbertson E, Barrett HL et al (2019) Primary hyperparathyroidism in pregnancy: maternofetal outcomes at a Quaternary Referral Obstetric Hospital, 2000 through 2015. J Clin Endocrinol Metab 104:721–729. https://doi.org/10.1210/jc.2018-01104
Cassir G, Sermer C, Malinowski AK (2020) Impact of perinatal primary hyperparathyroidism on maternal and fetal and neonatal outcomes: retrospective case series. J Obstet Gynaecol Can 42:750–756. https://doi.org/10.1016/j.jogc.2019.12.017
Bharati P, Pal M, Bandyopadhyay M et al (2011) Prevalence and causes of low birth weight in India. Malays J Nutr 17:301–313
Funding
None.
Author information
Authors and Affiliations
Contributions
RP is the primary author. SKB is the corresponding author, had conceptualized and edited the manuscript. NG, AA, KVR, GK and SMA had helped in data collection. AB had been the operating surgeon. NA had been the treating gynecologist. UNS had been the histopathologist. RW had edited the manuscript. All the authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
Obtained from Institute Ethics Committee, PGIMER, Chandigarh, India.
Research involving human participants and/or animals
No animals were used for this study.
Informed consent
Formal consent was obtained from all the participants.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pal, R., Bhadada, S.K., Gupta, N. et al. Primary hyperparathyroidism in pregnancy: observations from the Indian PHPT registry. J Endocrinol Invest 44, 1425–1435 (2021). https://doi.org/10.1007/s40618-020-01441-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-020-01441-z